Prakiraan rega marang bathi: aptorumgroup.com (APM)
Demand for orphan disease therapies is attracting leading scientists and medical professionals to Aptorum Group Limited (APM). The company's forward P/E NTM reflects market expectations, where the value of 0.00 characterizes this level. Revenues are based on partnership payments and the development of anti-staphylococcal agents. Crisis resilience is ensured by internal development cycles and the commercialization of innovations that remain independent of macroeconomic trends.
Rincian metrik keuangan lan pasar Aptorum (APM)
- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas Aptorum Group Limited|APM - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Aptorum Group Limited|APM - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Aptorum Group Ltd|APM - Kewajiban jangka dawa|Kewajiban jangka cendhak perusahaan Aptorum Group|Likuiditas cepet aptorumgroup.com
- statistik bathi lan rasio pasar:
APM - Penghasilan resik perusahaan|Bathi sing dikarepake Aptorum Group Limited|APM - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Aptorum Group Limited|APM - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Aptorum Group Ltd|APM - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Aptorum Group|APM - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan aptorumgroup.com|APM - Owah-owahan bathi resik saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Aptorum Group Limited
Analisis komprehensif perusahaan:APM Aptorum Group
The development of innovative therapies by Aptorum Group Limited is constrained by sanction barriers and disruptions in biomaterial logistics, creating risks for the realization of its research potential. The relationship between the current price and projected earnings, reflected through the company's expected P/E ratio, quantifies these expectations, allowing investors to assess the asset's degree of overvaluation and determine the capital's margin of safety amid high uncertainty.
Analisis pesaing Aptorum Group Limited
Rega marang bathi mangsa ngarep Haleon (HLN)|KVUE - Rasio prakiraan rega marang bathi|Verona Pharma Corp - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep MENS (Jyong Bio)|Ligand Pharmaceuticals - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi AMRX (amneal.com)|PRGO: Pangali Forward P/E|Rasio prakiraan rega marang bathi Alvotech S.A. (ALVO)|Rega marang bathi mangsa ngarep Liquidia Technologies|GLPG: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ANIP|Pangali Forward P/E mannkindcorp.com (MNKD)|Rega marang bathi mangsa ngarep Amphastar Pharmaceuticals, Inc. AMPH|PCRX (Pacira Pharmaceuticals) - Rasio rega marang bathi sing dikarepake|SPRY: Prakiraan rega marang bathi|Theravance Corp - Rasio kapitalisasi marang bathi mangsa ngarep|Aquestive Therapeutics (AQST) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi scPharmaceuticals (SCPH)|Rega marang bathi mangsa ngarep Tectonic Therapeutic Inc.|TNXP: Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi SXTC (China SXT Pharmaceuticals)|Pangali Forward P/E eupraxiapharma.com (EPRX)|Rega marang bathi mangsa ngarep BioHarvest Sciences BHST|EXOZ - Prakiraan rega marang bathi|ORMP: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ENTX (Entera Bio Ltd.)|HYFT: Pangali Forward P/E|Pangali forward rega marang bathi ABVC BioPharma, Inc ABVC|Rega marang bathi mangsa ngarep Cumberland Pharmaceuticals|QNTM: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep FibroGen (FGEN)|TELO - Rasio prakiraan rega marang bathi|Rani Therapeutics Holdings, Inc. - Prakiraan rega marang bathi|Pangali Forward P/E Synergy CHC Corp. SNYR|RLYB - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake LEXX|PULM (Pulmatrix) - Prakiraan rega marang bathi|Pheton Holdings - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Lyra Therapeutics, Inc|Rega marang bathi mangsa ngarep IBO|Pangali Forward P/E TNFA|Kapitalisasi marang proyeksi bathi cbdmd.com|Rega marang bathi mangsa ngarep PainReform PRFX|CYTO - Prakiraan rega marang bathi|Lipella - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi OptiNose Corp OPTN|PIRS (Pieris Pharmaceuticals) - Prakiraan rega marang bathi|PROC: Rasio kapitalisasi marang bathi mangsa ngarep|PTPI (Petros Pharmaceuticals, Inc.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Qilian International Holding Group QLI|Pangali Forward P/E SLRN|TFF Pharmaceuticals, Inc - Rasio rega marang bathi mangsa ngarep
